| Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases H Zhong, AM De Marzo, E Laughner, M Lim, DA Hilton, D Zagzag, ... Cancer research 59 (22), 5830-5835, 1999 | 3612 | 1999 |
| Identification of a chromosome 18q gene that is altered in colorectal cancers ER Fearon, KR Cho, JM Nigro, SE Kern, JW Simons, JM Ruppert, ... Science 247 (4938), 49-56, 1990 | 2332 | 1990 |
| Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells … H Zhong, K Chiles, D Feldser, E Laughner, C Hanrahan, MM Georgescu, ... Cancer research 60 (6), 1541-1545, 2000 | 2072 | 2000 |
| In vivo molecular and cellular imaging with quantum dots X Gao, L Yang, JA Petros, FF Marshall, JW Simons, S Nie Current opinion in biotechnology 16 (1), 63-72, 2005 | 1605 | 2005 |
| Nanotechnology applications in cancer S Nie, Y Xing, GJ Kim, JW Simons Annu. Rev. Biomed. Eng. 9 (1), 257-288, 2007 | 1481 | 2007 |
| The genomic complexity of primary human prostate cancer MF Berger, MS Lawrence, F Demichelis, Y Drier, K Cibulskis, ... Nature 470 (7333), 214-220, 2011 | 1440 | 2011 |
| Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response ER Fearon, DM Pardoll, T Itaya, P Golumbek, HI Levitsky, JW Simons, ... Cell 60 (3), 397-403, 1990 | 1257 | 1990 |
| Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group GJ Bubley, M Carducci, W Dahut, N Dawson, D Daliani, M Eisenberger, ... Journal of Clinical Oncology 17 (11), 3461-3467, 1999 | 1139 | 1999 |
| Phenotype of mice lacking functional Deleted in colorectal cancer (Dec) gene A Fazeli, SL Dickinson, ML Hermiston, RV Tighe, RG Steen, CG Small, ... Nature 386 (6627), 796-804, 1997 | 966 | 1997 |
| 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF NJ Mabjeesh, D Escuin, TM LaVallee, VS Pribluda, GM Swartz, ... Cancer cell 3 (4), 363-375, 2003 | 923 | 2003 |
| Levels of hypoxia-inducible factor-1α during breast carcinogenesis R Bos, H Zhong, CF Hanrahan, ECM Mommers, GL Semenza, HM Pinedo, ... Journal of the national cancer institute 93 (4), 309-314, 2001 | 883 | 2001 |
| Expression of hypoxia‐inducible factor 1α in brain tumors: association with angiogenesis, invasion, and progression D Zagzag, H Zhong, JM Scalzitti, E Laughner, JW Simons, GL Semenza Cancer: Interdisciplinary International Journal of the American Cancer …, 2000 | 849 | 2000 |
| Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells R Rodriguez, ER Schuur, HY Lim, GA Henderson, JW Simons, ... Cancer research 57 (13), 2559-2563, 1997 | 804 | 1997 |
| Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate JB Nelson, SP Hedican, DJ George, AH Reddi, S Piantadosi, ... Nature medicine 1 (9), 944-949, 1995 | 788 | 1995 |
| Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry Y Xing, Q Chaudry, C Shen, KY Kong, HE Zhau, LW Chung, JA Petros, ... Nature protocols 2 (5), 1152-1165, 2007 | 662 | 2007 |
| Direct comparison of GAPDH, β-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia H Zhong, JW Simons Biochemical and biophysical research communications 259 (3), 523-526, 1999 | 636 | 1999 |
| Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte … JW Simons, B Mikhak, JF Chang, AM DeMarzo, MA Carducci, M Lim, ... Cancer research 59 (20), 5160-5168, 1999 | 565 | 1999 |
| Tracking the clonal origin of lethal prostate cancer MC Haffner, T Mosbruger, DM Esopi, H Fedor, CM Heaphy, DA Walker, ... The Journal of clinical investigation 123 (11), 4918-4922, 2013 | 545 | 2013 |
| Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by ex Vivo Granulocyte-Macrophage Colony-stimulating Factor Gene Transfer JW Simons, EM Jaffee, CE Weber, HI Levitsky, WG Nelson, MA Carducci, ... Cancer research 57 (8), 1537-1546, 1997 | 541 | 1997 |
| A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy TL DeWeese, H van der Poel, S Li, B Mikhak, R Drew, M Goemann, ... Cancer research 61 (20), 7464-7472, 2001 | 531 | 2001 |
